Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause

Inclusion Criteria: * Patients with surgical menopause attending IHSS outpatient clinic. * Patients with surgical menopause with presence of hot flashes and night sweats. * Surgical menopausal patients with episodes of anxiety and palpitations. * Patients with surgical menopause who receive treatment for 6 months with Paroxetine. * Patients who after reading and explanation of the Informed Consent agree to participate voluntarily. Exclusion Criteria: * Patients medicated with psychotropic drugs, including all sedatives and hypnotics. * Patients under treatment with Menopausal Hormone Therapy. * Patients with impaired hepatic or renal function. * Patients with unstable heart disease. * Patients with a history of self-destructive behaviors. * Patients with a history of clinical diagnosis or treatment for depression or any other psychiatric disorder (including substance abuse or alcohol disorders) and any other ongoing medical condition.